Parrhesia β’ 494 implied HN points β’ 09 Mar 24
- Several scientists and professional organizations criticize polygenic embryo screening for polygenic disorders due to concerns like lack of validation and utility.
- The article argues that the recommendation against polygenic embryo screening is flawed because it doesn't compare the method to other acceptable alternatives like selection based on embryo morphology.
- The authors suggest that the critique against polygenic embryo screening lacks consideration of the ethical implications and does not provide a comprehensive cost-benefit analysis.